Skip to main content

Displaying 229 - 240 of 418

Hot Corner Insider

Director Breitner Buys 750,000 WOOF Shares

May 29, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes via a Form 4 filing by Petco Health and Wellness Company $WOOF director Cameron Breitner.

Breitner reported the acquisition of 750,000 shares of WOOF, equivalent to $2,354,325.

Hot Corner Insider

CEO Svoboda Buys 2,500 GL Shares

May 22, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The only insider buy on today’s list comes via a Form 4 filing by the co-chairman and CEO of Globe Life Inc $GL, Frank M. Svoboda.

Svoboda reported the acquisition of 2,500 GL shares, equivalent to $205,684.

Hot Corner Insider

CEO Siegall Reports a $1.3 Million IMNM Purchase

May 21, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider buy on today’s list comes via a Form 4 filing by Clay B. Siegall, president and CEO of Immunome Inc $IMNM.

Siegall reported a purchase of $1.3 million worth of IMNM shares.

Hot Corner Insider

CEO Girsky Buys 1 Million NKLA Shares

May 20, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider buy on today’s list comes via a Form 4 filing by the CEO of Nikola Corporation $NKLA, Stephen J. Girsky.

Girsky reported the acquisition of 1 million NKLA shares for approximately $0.54 per share, paying a total amount of $540,000.

Hot Corner Insider

Director Mohn Reports a $12 Million RIG Purchase

May 19, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider buy on today’s list comes via a Form 4 filing by Transocean Ltd $RIG director Frederik Wilhelm Mohn.

Mohn reported a purchase of RIG shares with a total value of $12,020,000.

Hot Corner Insider

Director Kim Buys 25,000 TRDA Shares

May 16, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The only insider buy on today’s list comes via a Form 4 filing by Entrada Therapeutics Inc $TRDA director Peter S. Kim.

Kim reported the acquisition of 25,000 shares, equivalent to $364,672, in the small-cap biotech company.